Removal of melatonin receptor type 1 induces insulin resistance in the mouse

Susana Contreras-Alcantara1, Kenkichi Baba, Gianluca Tosini

  • 1Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, Georgia, USA.

Insights

Melatonin receptor type 1 (MT1) is crucial for glucose metabolism. Mice lacking MT1 receptors show impaired glucose metabolism, likely due to increased insulin resistance, suggesting MT1

Area of Science:

  • Metabolic disease research
  • Endocrinology
  • Molecular biology

Background:

  • Global rise in obesity, insulin resistance, and type 2 diabetes (T2D).
  • Emerging evidence implicates the hormone melatonin in glucose metabolism regulation.

Purpose of the Study:

  • Investigate the role of melatonin receptor type 1 (MT1) in glucose metabolism.
  • Determine if MT1 receptor deficiency affects insulin resistance and glucose tolerance.

Main Methods:

  • Utilized a mouse model lacking the MT1 receptor.
  • Assessed glucose metabolism and insulin resistance in these mice.

Main Results:

  • Mice lacking MT1 receptors exhibited significantly impaired glucose metabolism.
  • This impairment is likely associated with increased insulin resistance.

Conclusions:

  • MT1 receptors play a significant role in maintaining normal glucose homeostasis.
  • MT1 receptor signaling is implicated in the pathogenesis of type 2 diabetes.
  • Further research into MT1 receptor mechanisms in glucose metabolism is warranted.

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...